ABUS vs MTCH
Arbutus Biopharma Corp (ABUS) versus Match Group Inc (MTCH) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Match Group Inc (MTCH) is a internet content & information company listed on NASDAQ.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported MTCH revenue for 2024-12-31 was $3.48B. Net income was $551.3M. Revenue was up 3.4% from 2023-12-31 to 2024-12-31. MTCH currently screens at market cap $8.24B and trailing P/E 13.5.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. MTCH currently screens at market cap $8.24B and trailing P/E 13.5.
Not investment advice. Open the ABUS and MTCH stock pages for the full models.
Not investment advice.